Alsya Affandi | Lead Scientist, CSO Immunara
Amsterdam UMC

Alsya Affandi is a Lead Scientist at Amsterdam UMC and Chief Scientific Officer (CSO) at Immunara, an academic spinout, with a strong background in immunology. He focuses on harnessing antigen-presenting cell biology for next-generation biologic therapies, with an emphasis on improving anti-tumor immune responses through targeted antigen delivery strategies. At Immunara, Alsya leads scientific strategy and business development for novel single-domain antibody (sdAb)–based platforms aimed at enhancing immune activation and improving therapeutic outcomes across cancer and other disease areas. His work bridges academic research and translational development, drawing on experience from Amsterdam UMC, as well as previous affiliations at UMC Utrecht and Boston University. He has contributed to multiple high impact publications, including in the New England Journal of Medicine (NEJM) and Proceedings of the National Academy of Sciences (PNAS), reflecting his work at the interface of fundamental immunology and translational medicine. He also holds one patent in the field of immunotherapy and is committed to developing innovative therapies that address current limitations in cancer treatment and improve patient outcomes.